Evidence map›Paper›PMID 40585285›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2025

[

David L Chan, Alice Conner, Nick Pavlakis, Elizabeth Bailey, Alireza Aslani, Kathy Willowson, Connie Diakos, Elizabeth J Bernard, Stephen Clarke, Alexander Engel and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David L ChanFaculty of Medicine and Health, University of Sydney, Camperdown, Australia and Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.
Alice ConnerFaculty of Medicine and Health, University of Sydney, Camperdown, Australia.
Nick PavlakisFaculty of Medicine and Health, University of Sydney, Camperdown, Australia and Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.
Elizabeth BaileyDepartment of Nuclear Medicine, Royal North Shore Hospital, St Leonards, Australia.
Alireza AslaniDepartment of Nuclear Medicine, Royal North Shore Hospital, St Leonards, Australia.
Kathy WillowsonDepartment of Nuclear Medicine, Royal North Shore Hospital, St Leonards, Australia.
Connie DiakosFaculty of Medicine and Health, University of Sydney, Camperdown, Australia and Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.
Elizabeth J BernardDepartment of Nuclear Medicine, Royal North Shore Hospital, St Leonards, Australia.
Stephen ClarkeFaculty of Medicine and Health, University of Sydney, Camperdown, Australia and Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.
Alexander EngelFaculty of Medicine and Health, University of Sydney, Camperdown, Australia.
Paul J RoachFaculty of Medicine and Health, University of Sydney, Camperdown, Australia and Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.
Dale L BaileyFaculty of Medicine and Health, University of Sydney, Camperdown, Australia and Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The phenomenon of peripheral [ Methods: Prospective pilot study in patients with metastatic NENs with at least one DONUT lesion (central [ Results: Ten patients were enrolled with primary sites including pancreas (n=3), small bowel (n=3), rectum (n=2), duodenum (n=1) and lung (n=1). Six subjects were scored 1, three subjects were scored 2, and one subject was scored 3. All lesions evaluated were located in the liver. Quantitative [ Conclusion: Only one of ten patients with DONUT lesions demonstrated increased [

Indexed as

[18F]FDG[18F]FMISO[68Ga]DOTATATEHypoxiaNeuroendocrine tumours (NETs)PET/CT

Identifiers

PMID40585285
PMCPMC12205124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.